Switching from biosimilar adalimumab to originator adalimumab and vice versa as an alternative to target switch in patients with hidradenitis suppurativa: a single center experience

被引：0
|
作者：
Roldan, Fernando Alfageme [1 ]
Cembrero, Hirune [1 ]
Salguero, Irene [1 ]
Martinez, Constanza [1 ]
Roustan, Gaston [1 ]
机构：
[1] Hosp Univ Puerta de Hierro Majadahonda, Dermatol, Madrid, Spain
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P167
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [21] REAL-WORLD EXPERIENCE ON SWITCHING ADALIMUMAB ORIGINATOR TO BIOSIMILAR IN INFLAMMATORY ARTHRITIS - A RETROSPECTIVE STUDY
    Yeoh, S. A.
    Saxby, K.
    Barron, A.
    Moore, S.
    Gani, S.
    Ehrenstein, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1458 - 1458
  • [22] Switching from adalimumab originator to ABP 501 biosimilar: a multicentre North Italian study
    Barberio, B.
    Melatti, P.
    Zingone, F.
    Bertani, L.
    Ferronato, A.
    Gubbiotti, A.
    Massimi, D.
    D'Inca, R.
    Savarino, E. V.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S414 - S414
  • [23] Switching from adalimumab originator to biosimilar: a 3-year retrospective cohort analysis
    Killion, Lisa
    Alsharqi, Ali
    Kirby, Brian
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [24] Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis
    Loft, Nikolai
    Egeberg, Alexander
    Rasmussen, Mads Kirchheiner
    Bryld, Lars Erik
    Nissen, Christoffer Valdemar
    Dam, Tomas Norman
    Ajgeiy, Kawa Khaled
    Iversen, Lars
    Skov, Lone
    JAMA DERMATOLOGY, 2021, 157 (06) : 676 - 683
  • [25] Switching from adalimumab originator to biosimilar: a 3-year retrospective cohort analysis
    Killion, Lisa
    Alsharqi, Ali
    Kirby, Brian
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (04) : 397 - 398
  • [26] The impact of adalimumab on the intimacy of hidradenitis suppurativa patients: Experience of a dermatology unit in Portugal
    Caldas, Regina
    Almeida, Filipa Tavares
    Guimaraes, Maria Jose
    Lopes, Ana Gabriela
    Pereira, Teresa
    Brito, Celeste
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB101 - AB101
  • [27] NON MEDICAL SWITCH FROM ADALIMUMAB ORIGINATOR TO THE BIOSIMILAR GP2017 IN PATIENTS AFFECTED BY CHRONIC ARTHRITIS
    Colaci, M.
    Aprile, M. L.
    La Rosa, A.
    Di Maggio, A.
    Malatino, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1135 - 1135
  • [28] Adopting adalimumab combined surgery in the management of moderate to severe hidradenitis suppurativa: Experience from a single medical center in southern Taiwan
    Lai, Po-Ta
    Tseng, Han-Chi
    JOURNAL OF DERMATOLOGY, 2024, 51 (12): : 1615 - 1621
  • [29] Treating hidradenitis suppurativa patients with adalimumab: a real-life experience of a tertiary care center in Lisboa, Portugal
    Neves, Jose Miguel
    Cunha, Nelia
    Lencastre, Andre
    Cabete, Joana
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2022, 97 (06) : 816 - 819
  • [30] Switching From Originator Adalimumab to the Biosimilar SB5 in Patients With Inflammatory Bowel Disease: Short-term Experience From a Single Tertiary Clinical Centre
    Lukas, Martin
    Malickova, K.
    Kolar, M.
    Bortlik, M.
    Vasatko, M.
    Machkova, N.
    Hruba, V
    Duricova, D.
    Lukas, Milan
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (07): : 915 - 919
12345